RE:Time WarpIf you want to take it back even further, the patents that WR Partners licensed from UBC were originally financed by both Synapse Technologies Inc. and UBC in the period from 1992-2002. The US Biotech firm BIOMARIN then bought Synapse in 2002. At some point in time after that the patents were returned to UBC and then became available to WR Partners. I suspect that the development of the peptide was a useful means to extend patent life as well as decrease manufacturing costs and improve transport characteristics.